138 related articles for article (PubMed ID: 9844355)
1. Appearance of Graves'-like disease following regression of autonomously functioning thyroid nodules. Two case reports.
Orsolon P; Lupi A; De Antoni Migliorati G; Vianello Dri A
Minerva Endocrinol; 1998 Jun; 23(2):53-6. PubMed ID: 9844355
[TBL] [Abstract][Full Text] [Related]
2. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy.
Nygaard B; Faber J; Veje A; Hegedüs L; Hansen JM
Thyroid; 1999 May; 9(5):477-81. PubMed ID: 10365679
[TBL] [Abstract][Full Text] [Related]
3. Appearance of anti TSH-receptor antibodies and clinical Graves' disease after radioiodine therapy for hyperfunctioning thyroid adenoma.
Regalbuto C; Salamone S; Scollo C; Vigneri R; Pezzino V
J Endocrinol Invest; 1999 Feb; 22(2):147-50. PubMed ID: 10195384
[TBL] [Abstract][Full Text] [Related]
4. Appearance of thyroid stimulating antibody and Graves' disease after radioiodine therapy for toxic nodular goitre.
Chiovato L; Santini F; Vitti P; Bendinelli G; Pinchera A
Clin Endocrinol (Oxf); 1994 Jun; 40(6):803-6. PubMed ID: 8033373
[TBL] [Abstract][Full Text] [Related]
5. Toxic multinodular goiter: a variant of autoimmune hyperthyroidism.
Kraiem Z; Glaser B; Yigla M; Pauker J; Sadeh O; Sheinfeld M
J Clin Endocrinol Metab; 1987 Oct; 65(4):659-64. PubMed ID: 2888784
[TBL] [Abstract][Full Text] [Related]
6. The role of thyroid scanning in hyperthyroidism.
Fogelman I; Cooke SG; Maisey MN
Eur J Nucl Med; 1986; 11(10):397-400. PubMed ID: 3009197
[TBL] [Abstract][Full Text] [Related]
7. Graves' disease triggered by autoinfarction of an autonomously functioning thyroid adenoma.
Gallegos E; Meier DA; Garcia M
J Nucl Med; 1997 Feb; 38(2):260-2. PubMed ID: 9025752
[TBL] [Abstract][Full Text] [Related]
8. The usefulness of conventional and echo colour Doppler sonography in the differential diagnosis of toxic multinodular goitres.
Boi F; Loy M; Piga M; Serra A; Atzeni F; Mariotti S
Eur J Endocrinol; 2000 Sep; 143(3):339-46. PubMed ID: 11022175
[TBL] [Abstract][Full Text] [Related]
9. Uptake of thallium-201 in enlarged thyroid glands: concise communication.
Fukuchi M; Kido A; Hyodo K; Tachibana K; Onoue K; Morita T; Nagai K
J Nucl Med; 1979 Aug; 20(8):827-32. PubMed ID: 94354
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous transition of an autonomously functioning thyroid adenoma to Graves' disease.
Bommireddipalli S; Gadiraju R; DePuey GE
Clin Nucl Med; 2009 Dec; 34(12):845-7. PubMed ID: 20139814
[TBL] [Abstract][Full Text] [Related]
11. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
[TBL] [Abstract][Full Text] [Related]
12. Disseminated thyroid autonomy or Graves' disease: reevaluation by a second generation TSH receptor antibody assay.
Meller J; Jauho A; Hüfner M; Gratz S; Becker W
Thyroid; 2000 Dec; 10(12):1073-9. PubMed ID: 11201852
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
[TBL] [Abstract][Full Text] [Related]
14. [Basedown disease, thyroid gland autonomy, nodular goiter. When is radiotherapy indicated?].
Dietlein M; Schicha H
MMW Fortschr Med; 2003 Apr; 145(17):47-9. PubMed ID: 12808806
[TBL] [Abstract][Full Text] [Related]
15. Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment.
Vitti P; Rago T; Chiovato L; Pallini S; Santini F; Fiore E; Rocchi R; Martino E; Pinchera A
Thyroid; 1997 Jun; 7(3):369-75. PubMed ID: 9226205
[TBL] [Abstract][Full Text] [Related]
16. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
Wallaschofski H; Kuwert T; Lohmann T
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
[TBL] [Abstract][Full Text] [Related]
17. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
[TBL] [Abstract][Full Text] [Related]
18. Hyperthyroidism due to Graves' disease and due to autonomous goiter.
Schicha H; Emrich D; Schreivogel I
J Endocrinol Invest; 1985 Oct; 8(5):399-407. PubMed ID: 3841136
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goiters.
Huysmans AK; Hermus RM; Edelbroek MA; Tjabbes T; Oostdijk ; Ross HA; Corstens FH; Kloppenborg PW
Thyroid; 1997 Aug; 7(4):535-9. PubMed ID: 9292939
[TBL] [Abstract][Full Text] [Related]
20. Thyroid nodules in Graves' disease: classification, characterization, and response to treatment.
Carnell NE; Valente WA
Thyroid; 1998 Aug; 8(8):647-52. PubMed ID: 9737358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
